Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Invus Public Equities, L.P.(1.9%),Invus Public Equities Advisors, LLC(1.9%)等
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(8.1%),Baker Bros. Advisors (GP) LLC(8.1%)等
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Redmile Group, LLC(3.9%),Jeremy C. Green(3.9%)
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(9.9%),Baker Bros. Advisors (GP) LLC(9.9%)等
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Point72 Asset Management, L.P.(3.6%),Point72 Capital Advisors, Inc.(3.6%)等
Achilles Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Invus Public Equities, L.P.(5.5%),Invus Public Equities Advisors, LLC(5.5%)等
Achilles Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(3.93%),Peter Kolchinsky(3.93%)等
Achilles Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(7.27%),Peter Kolchinsky(7.27%)等
Achilles Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(10.03%),Peter Kolchinsky(10.03%)等
Achilles Therapeutics | SC 13G:超过5%持股股东披露文件-Point72 Asset Management, L.P.(5.3%),Point72 Capital Advisors, Inc.(5.3%)等
Achilles Therapeutics | SC 13G:超过5%持股股东披露文件-Redmile Group, LLC(5.1%),Jeremy C. Green(5.1%)
Achilles Therapeutics | SC 13G:超过5%持股股东披露文件-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%)等
Achilles Therapeutics | SC 13G:超过5%持股股东披露文件
Achilles Therapeutics | SC 13G:超过5%持股股东披露文件-Forbion Capital Fund IV Coöperatief U.A.(5.89%),Forbion IV Management B.V.(5.89%)
Achilles Therapeutics | SC 13D:超过5%持股股东披露文件
Achilles Therapeutics | SC 13G:超过5%持股股东披露文件
暂无数据